AU5849796A - Peptide ratchet libraries for ctl-inducing vaccines and therapeutics - Google Patents

Peptide ratchet libraries for ctl-inducing vaccines and therapeutics

Info

Publication number
AU5849796A
AU5849796A AU58497/96A AU5849796A AU5849796A AU 5849796 A AU5849796 A AU 5849796A AU 58497/96 A AU58497/96 A AU 58497/96A AU 5849796 A AU5849796 A AU 5849796A AU 5849796 A AU5849796 A AU 5849796A
Authority
AU
Australia
Prior art keywords
ctl
therapeutics
libraries
ratchet
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58497/96A
Inventor
Peter J Kuebler
Douglas F Nixon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Biomedical Inc
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of AU5849796A publication Critical patent/AU5849796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU58497/96A 1994-12-27 1995-12-15 Peptide ratchet libraries for ctl-inducing vaccines and therapeutics Abandoned AU5849796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36633294A 1994-12-27 1994-12-27
US366332 1994-12-27
PCT/US1995/016290 WO1996022067A2 (en) 1994-12-27 1995-12-15 Peptide ratchet libraries for ctl-inducing vaccines and therapeutics

Publications (1)

Publication Number Publication Date
AU5849796A true AU5849796A (en) 1996-08-07

Family

ID=23442575

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58497/96A Abandoned AU5849796A (en) 1994-12-27 1995-12-15 Peptide ratchet libraries for ctl-inducing vaccines and therapeutics

Country Status (2)

Country Link
AU (1) AU5849796A (en)
WO (1) WO1996022067A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252829B1 (en) * 1998-06-17 2007-08-07 Idm Pharma, Inc. HLA binding peptides and their uses
US7611713B2 (en) 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
US9266930B1 (en) 1993-03-05 2016-02-23 Epimmune Inc. Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
US6495314B1 (en) * 1995-09-29 2002-12-17 The Scripps Research Institute Process for characterizing proteins
WO1997041440A1 (en) * 1996-04-26 1997-11-06 Rijksuniversiteit Te Leiden Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
DE69842060D1 (en) * 1997-05-08 2011-01-27 Oncothyreon Inc Method of obtaining activated T cells and antigen-incubated antigen-presenting cells
EP1369428A1 (en) * 1997-10-31 2003-12-10 Biomira Inc. Muc-1 derivatives and their use in treating cancer-associated MUC-1 Mucin-induced immunosuppression
WO1999023114A1 (en) * 1997-10-31 1999-05-14 Biomira Inc. Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression
JP4394279B2 (en) 1998-03-09 2010-01-06 ジーランド ファーマ アクティーゼルスカブ Pharmacologically active peptide conjugates with reduced propensity to enzymatic hydrolysis
GB9904695D0 (en) * 1999-03-01 1999-04-21 Imp Cancer Res Tech Peptide
SE9903031D0 (en) * 1999-08-27 1999-08-27 Eurodiagnostica Ab Peptide mixture and vaccine against a chronic viral infection
EP1230268B1 (en) 1999-11-18 2009-10-14 Pharmexa Inc. Heteroclitic analogs of class i epitopes
US7026443B1 (en) 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
RU2172322C1 (en) * 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Allopherones as immunomodulating peptides
FR2809402A1 (en) * 2000-05-26 2001-11-30 Dev Des Antigenes Combinatoire CONVERGENT COMBINATORY PEPTIDE LIBRARIES AND THEIR APPLICATION TO VACCINATION AGAINST HEPATITIS C VIRUS
DE102009034779A1 (en) 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetic analogues of bacterial lipopeptides and their application for the therapy and prophylaxis of allergic diseases
WO2012082803A2 (en) * 2010-12-13 2012-06-21 Cel-Sci Corporation Method for inducing an immune response against avian, swine, spanish, h1n1, h5n9 influenza viruses and formulations thereof
WO2012162564A1 (en) 2011-05-25 2012-11-29 Cel-Sci Corporation Method for inducing an immune response and formulations thereof
WO2023023523A1 (en) * 2021-08-16 2023-02-23 Duke University Next generation vaccines comprising antigenic libraries and methods of making and using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof

Also Published As

Publication number Publication date
WO1996022067A2 (en) 1996-07-25
WO1996022067A3 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
AU5849796A (en) Peptide ratchet libraries for ctl-inducing vaccines and therapeutics
AU692612B2 (en) Peptide mixture and products thereof
AU4844893A (en) Peptide sequencing using mass spectrometry
AU6360394A (en) Vasonatrin peptide and analogs thereof
AU7043394A (en) Association peptides
AU4394396A (en) Modified peptides
AU2131195A (en) Prophenins - antibiotic peptides
GB9516293D0 (en) Novel peptides and their use as vaccines
AU1999999A (en) Contryphan peptides
GB9714276D0 (en) Peptides and related compounds
AUPN024994A0 (en) Assay and peptides for use therein
IL116658A0 (en) Peptides their preparation and use
AU3986397A (en) Human glycine transporter
AUPM489194A0 (en) Peptides
AU4285296A (en) Bradykinin antagonist peptides containing indane-sustituted amino acids
AU5161296A (en) Anti-haemorrhagic peptides
GB9606272D0 (en) Gene and peptides
AU2786297A (en) Virginiamycin mixture
AUPM473294A0 (en) Peptides for diagnostics and therapeutics
AU1860397A (en) Ebna2 peptides and methods of using same
GB9519511D0 (en) Peptides
AU4406197A (en) Cysteine containing peptides
AU4328500A (en) Retro-inverso prosaposin-derived peptides and use thereof
AU3338195A (en) Allergen peptides
AU9109098A (en) Hypusine peptides